251 Views

AACE Annual Meeting

Nutrition and Obesity

One Size Doesn’t Fit All: Pharmacotherapy, Endoscopic Devices and Metabolic Surgery for the Management of Obesity

Pharmacological Management of Obesity and Newer Drugs on the Horizon

Saturday, May 14, 2022

3:15 PM – 3:30 PM

Location: Main Stage - Sapphire IJMN (Level 4)

Speaker(s)

Holly F. Lofton, MD, DiplABOM
Clinical Associate Professor of Surgery and Medicine
NYU Grossman School of Medicine
New York, New York, United States

Disclosure: Eli Lilly (Self) : Research Grant (Status: Ongoing); Novo Nordisk (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing), Honorarium (Status: Ongoing), Research Grant (Status: Ongoing)

PDF Slides

Learning Objectives:

Define patient populations eligible for weight management pharmacotherapy
Discuss the mechanism of action of currently available drugs and those on the horizon
Estimate expected weight loss outcomes of currently available drugs and those on the horizon

Participants should be aware of the following financial/non-financial relationships:

Holly F. Lofton, MD, DiplABOM: Eli Lilly (Individual(s) Involved: Self): Research Grant; Novo Nordisk (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Honorarium, Research Grant